Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Fate Therapeutics
(NQ:
FATE
)
2.680
-0.080 (-2.90%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Fate Therapeutics
< Previous
1
2
3
4
5
6
7
8
9
Next >
Fate Therapeutics' Stem Cell-Derived NK Lymphoma Candidate Casts Doubt Over Durability Of Response
August 20, 2021
Fate Therapeutics Inc (NASDAQ: FATE) revealed an early cut of Phase I data for its FT596 and FT516 programs for relapsed / refractory B-cell lymphoma. At the 2021...
Via
Benzinga
Fate Stock Collapses As Investors Question Its Cancer Drug's Durability
August 19, 2021
Fate Therapeutics unveiled mixed results for its lymphoma treatment late Thursday, and Fate stock crumbled in after-hours action.
Via
Investor's Business Daily
The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck
August 19, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow
August 15, 2021
Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small-...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Fate Therapeutics, inc (FATE) Q2 2021 Earnings Call Transcript
August 06, 2021
FATE earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Did You See What Cathie Wood Bought on Wednesday?
July 22, 2021
ARK Invest added to its stakes in DraftKings, Fate Therapeutics, and Zoom Video, all of which are trading well below their recent peaks.
Via
The Motley Fool
Unusual Options Activity Insight: Fate Therapeutics
July 12, 2021
On Monday, shares of Fate Therapeutics (NASDAQ:FATE) saw unusual options activity. After the option alert, the stock price moved down to $88. Sentiment: BEARISH Option Type:...
Via
Benzinga
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
August 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....
Via
Benzinga
Exposures
Product Safety
Elliott Wave Technical Analysis For Six US Stocks - CDNA, CRWD, FATE, UPS, HDB, SPOT
July 03, 2021
CareDx, CrowdStrike, Fate Therapeutics, HDFC Bank, Spotify, UPS - Daily charts.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2021
June 07, 2021
Upgrades Deutsche Bank upgraded the previous rating for Marriott Vacations Worldwide Corp (NYSE:VAC) from Hold to Buy. Marriott Vacations earned $0.49 in the first quarter...
Via
Benzinga
Fate Therapeutics Stock is Trading Higher on Positive B-Cell Lymphoma Data at ASCO21
June 04, 2021
Fate Therapeutics Inc (NASDAQ: FATE) has revealed some new data from an ongoing Phase 1 trial evaluating FT516 for patients with relapsed / refractory B-cell...
Via
Benzinga
Fate Therapeutics' iPSC-Derived Cell Therapies Induce Leukemic Blast Clearance, Show Durable Remissions In AML Patients
May 14, 2021
Fate Therapeutics Inc (NASDAQ: FATE) has announced interim data from Phase 1 data from the Company's off-the-shelf, iPSC-derived natural killer (NK) cell...
Via
Benzinga
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
May 31, 2021
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Thursday's After-Market Session
May 13, 2021
Gainers Bionano Genomics (NASDAQ:BNGO) st...
Via
Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use
May 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc...
Via
Benzinga
Exposures
COVID-19
Cathie Wood Loads Up $57M In Palantir As Stock Stages Reversal On Q1 Earnings Beat
May 12, 2021
Cathie Wood-led Ark Investment Management on Tuesday snapped up 2.8 million shares, worth about $56.7 million, in Palantir Technologies Inc (NYSE: PLTR) after the data analytics...
Via
Benzinga
Cathie Wood Loads Up Another $28M Worth Of Shares In Alibaba Rival JD.Com
May 09, 2021
Cathie Wood-led Ark Investment Management on Friday bought 366,879 shares, worth about $27.7 million, in JD.com Inc (NASDAQ: JD), a key rival to Alibaba Group Holding (NYSE: BABA...
Via
Benzinga
Cathie Wood Cuts Apple Stake By 30% And Buys Coinbase, DraftKings
May 10, 2021
Cathie Wood-led Ark Investment Management shed more shares of Apple Inc (NASDAQ:
Via
Benzinga
Fate Therapeutics Inc (FATE) Q1 2021 Earnings Call Transcript
May 06, 2021
FATE earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Preview: Fate Therapeutics's Earnings
May 04, 2021
On Wednesday, May 05, Fate Therapeutics (NASDAQ:FATE) will release its latest earnings report. Benzinga's outlook for Fate Therapeutics is included in the following report. Net...
Via
Benzinga
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
May 09, 2021
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...
Via
Benzinga
Exposures
COVID-19
Product Safety
Cathie Wood Slashes Apple Stake To Half — Also Trims Google, Fastly: What You Need To Know
May 07, 2021
Cathie Wood-led Ark Investment Management nearly halved the Apple Inc (NASDAQ: AAPL) stake in the ARK Fintech Innovation ETF (NYSE: ARKF) on Thursday. ARKF shed 298,505 Apple...
Via
Benzinga
Cathie Wood Buys Yet Another Workhorse Dip, Also Adds DraftKings, Peloton, Square
April 13, 2021
Cathie Wood-led Ark Investment Management on Monday bought in more shares of the electric vehicle company Workhorse Group Inc (NASDAQ: WKHS) on a day the stock fell about 6% to $...
Via
Benzinga
Topics
Electric Vehicles
Exposures
Electric Vehicles
LendingTree, Trimble, ICE, Fate Therapeutics — What Cathy Wood's Ark Bought And Sold On Tuesday
April 06, 2021
Cathie Wood’s Ark Investment Management sends out an email every night listing the stocks that were bought or sold by the firm's ETFs that day. In recent months, the...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.